Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Organic Letters|April 10, 2012
Highly efficient synthesis of a class of novel chiral-bridged atropisomeric monophosphine ligands via simple desymmetrization and their applications in asymmetric Suzuki-Miyaura coupling reactionShouliang Wang, Jinjin Li, Tingting Miao, et al.Cancer Drug Resistance (Alhambra, Calif.)|September 13, 2024
The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancerMeilan Zhang, Zhaokuan Zheng, Shouliang Wang, et al.Drug Design, Development and Therapy|May 23, 2019
Tetramethylpyrazine attenuated bupivacaine-induced neurotoxicity in SH-SY5Y cells through regulating apoptosis, autophagy and oxidative damageShouliang Wang, Bin Xia, Zonglei Qiao, et al.Research (Washington, D.C.)|June 25, 2025
Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New FrontierShouliang Wang, Shun Li, Mengli Zhang, et al.Organic Letters|October 22, 2013
Enantioselective synthesis of axially chiral multifunctionalized biaryls via asymmetric Suzuki-Miyaura couplingYougui Zhou, Shouliang Wang, Wenhao Wu, et al.Signal Transduction and Targeted Therapy|August 15, 2023
The mitophagy pathway and its implications in human diseasesShouliang Wang, Haijiao Long, Lianjie Hou, et al.Journal of Medicinal Chemistry|June 22, 2026
Utilizing Molecular Dynamics and Mechanistic Pharmacokinetic Studies in the Design of Selective CDK2 InhibitorsVishal A Verma, Jessica M Grandner, Brendan T Parr, et al.ACS Medicinal Chemistry Letters|June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State InhibitorsMichael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.ACS Medicinal Chemistry Letters|June 19, 2024
Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate BindingJun Liang, Michael J Lambrecht, Teresita L Arenzana, et al.Pageof 1